Opportunity Information: Apply for RFA AG 18 031
The National Institutes of Health (NIH) is offering a cooperative agreement opportunity (U01) titled "Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required)" under Funding Opportunity Number RFA-AG-18-031 (CFDA 93.866). The main purpose of this announcement is to support planning awards that help research teams develop, refine, and fully finalize the protocols needed to launch well-powered cognitive training intervention trials. These future trials are expected to test whether cognitive training can remediate or prevent age-related cognitive decline and, importantly, whether it might also prevent or delay the onset of mild cognitive impairment (MCI) and dementia. Because the mechanism is a U01 cooperative agreement, awardees should expect substantial scientific involvement from NIH program staff compared to a typical investigator-initiated grant, and the opportunity explicitly requires a clinical trial component.
This funding is focused on the groundwork that must be completed before a large, definitive trial can be conducted. Applicants are being asked to use the planning period to sharpen the intervention and the study methods so that the later-stage trial is feasible, rigorous, and adequately justified. Planning activities can include collecting pilot data, testing feasibility, and refining the cognitive training protocol itself in a way that aligns with Stage I of the NIH Stage Model for behavioral intervention development. In practical terms, that means investigators should be tightening the specifics of the training approach (content, dose, delivery platform, adherence strategies, fidelity monitoring, and participant engagement) while also working out recruitment pipelines, retention plans, and operational details that commonly determine whether a large trial succeeds.
A major emphasis of the opportunity is that proposed trial designs must clearly justify how cognition will be assessed and how mechanisms of change will be explored. In other words, it is not enough to propose that cognition will improve; applicants need to make a strong case that their measurement plan is sensitive, valid, and appropriate for the targeted cognitive domains and population, and that the design can plausibly detect meaningful changes. Beyond behavioral outcomes, the NIH is encouraging applicants to include measures that probe why and how training might work. Appropriate candidate tools mentioned in the announcement include structural and functional neuroimaging and biomarker approaches, as long as they are tied to a coherent underlying model of change. The RFA specifically notes biomarker strategies such as cerebrospinal fluid (CSF) measures and blood-based biomarkers as acceptable options when scientifically justified, reinforcing the expectation that applicants connect intervention effects to brain and biological pathways rather than treating mechanistic measures as add-ons.
Eligible applicants span a wide range of U.S.-based organizations, reflecting NIH's intent to support diverse institutional settings and partnerships. Eligibility includes state, county, city or township, and special district governments; federally recognized Native American tribal governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; public housing authorities and Indian housing authorities; tribal organizations that are not federally recognized tribal governments; nonprofits with and without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other eligible entities. The RFA also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible agencies of the federal government, tribal governments that are not federally recognized, and U.S. territories or possessions.
The geographic eligibility rules are specific: non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as applicants. However, non-domestic components of U.S. organizations are eligible, and foreign components are allowed as defined in the NIH Grants Policy Statement. This structure allows U.S.-led projects to incorporate international sites, collaborations, or specialized capabilities when justified, while keeping the applicant organization based in the United States.
Administratively, the opportunity was created on February 14, 2018, with an original closing date of April 30, 2018. The sponsoring agency is NIH, and the activity category is Health. While the summary information provided does not list an award ceiling or the expected number of awards, the intent is clear: to fund planning work that results in finalized, trial-ready protocols for robust cognitive training studies in older adults, with careful attention to outcome measurement and mechanistic understanding so that subsequent large-scale trials can be launched on solid scientific and operational footing.Apply for RFA AG 18 031
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Towards Implementing Novel Training Methods to Enhance Cognition in Aging (U01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2018-02-14.
- Applicants must submit their applications by 2018-04-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: FY2019 VANNEVAR BUSH FACULTY FELLOWSHIP (VBFF)
Previous opportunity: SCORE
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 18 031
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 18 031) also looked into and applied for these:
| Funding Opportunity |
|---|
| Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) Apply for PA 18 660 Funding Number: PA 18 660 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Validation of Candidate Biomarkers for Neurological Diseases (U01 Clinical Trial Optional) Apply for PAR 18 664 Funding Number: PAR 18 664 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional) Apply for PAR 18 665 Funding Number: PAR 18 665 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Research Mentoring Network: The Science of Mentoring, Networking, and Navigating Career Transition Points (U01 Clinical Trial Not Allowed) Apply for RFA RM 18 004 Funding Number: RFA RM 18 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Research Mentoring Network (NRMN) Resource Center (U24 - Clinical Trial Not Allowed) Apply for RFA RM 18 002 Funding Number: RFA RM 18 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Research Mentoring Network (NRMN) Coordination Center (U24 - Clinical Trial Not Allowed) Apply for RFA RM 18 003 Funding Number: RFA RM 18 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) Apply for PAR 18 669 Funding Number: PAR 18 669 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) Apply for PAR 18 679 Funding Number: PAR 18 679 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Administrative Supplement for the NIBIB Research Education Programs for Residents and Clinical Fellows (Admin Supp Clilnical Trial Not Allowed) Apply for PA 18 680 Funding Number: PA 18 680 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed) Apply for PA 18 682 Funding Number: PA 18 682 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) Apply for PAR 18 684 Funding Number: PAR 18 684 Agency: National Institutes of Health Category: Health Funding Amount: $1,515,000 |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) Apply for PAR 18 683 Funding Number: PAR 18 683 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) Apply for PAR 18 686 Funding Number: PAR 18 686 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) Apply for PAR 18 685 Funding Number: PAR 18 685 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition : HIV/AIDS-related Non-Human Primate Animal Research Facilities Restoration Program in the Aftermath of Hurricane Maria (C06 Clinical Trial Not Allowed) Apply for PAR 18 693 Funding Number: PAR 18 693 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID/Kyrgyz Republic Tuberculosis (TB) Control Program Apply for RFI 72011519RFA00001 Funding Number: RFI 72011519RFA00001 Agency: Kazakhstan USAID-Almaty Category: Health Funding Amount: Case Dependent |
| Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional) Apply for RFA NS 18 025 Funding Number: RFA NS 18 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 Clinical Trial Optional) Apply for PAR 18 694 Funding Number: PAR 18 694 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 18 696 Funding Number: PAR 18 696 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed) Apply for PA 18 699 Funding Number: PA 18 699 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 18 031", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
